Daily Financial News


Shire rejects $63 billion Takeda bid as Allergan drops pursuit

Shire rejects $63 billion Takeda bid as Allergan drops pursuitNEW YORK/LONDON (Reuters) - Rare disease drug maker Shire Plc (SHP.L) said on Thursday it had rejected a $63 billion (44.7 billion pounds) cash-and-stock acquisition offer by Japan's Takeda Pharmaceutical Co Ltd , while Allergan Plc (AGN.N) reversed course on pursuing a rival bid. An acquisition of Shire by Takeda would be by far the biggest acquisition of a drug company year-to-date. Botox-maker Allergan confirmed on Thursday it was considering an offer for Shire after Reuters reported on its interest, sending its shares down 7 percent.


agent photo
Adam Hopkins, Broker/Owner
MBA/CRS/ABR/SFR/GREEN
RE/MAX Community - FOREST VA
15421-C Forest Rd
Forest, VA 24551
call/text: 434-444-7136
email: adam@adamhopkins.net
online: www.adamhopkins.net

"Earning the right to be your Realtor for Life!"